# A Comparison of Saquinavir Hard- and Soft-Gelatin Capsules in HIV-Infected Patients

> **NCT00002383** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 80 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Saquinavir

## Key facts

- **NCT ID:** NCT00002383
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 80 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002383

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002383, "A Comparison of Saquinavir Hard- and Soft-Gelatin Capsules in HIV-Infected Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00002383. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*